←
Vantage Hemp Co.631 posts
Vantage Hemp Co. avatar

Vantage Hemp Co.

@vantagehemp

A globally accredited plant-based extractor and manufacturer built and operated to WHO GMP, FDA 21 CFR 210/211, PIC/S, and ICH Q7 standards.

◷ Joined August 2019▧ 496 Photos and videos
Vantage Hemp Co. avatar
Vantage Hemp Co.@vantagehemp·May 27

TUNE INTO @TheDalesReport AT 4:25PM EST Harv Johal (CRO) and Sean Karl (PM) explain how countries like Australia, Germany, Israel, and parts of Europe treat CBD APIs, GMP manufacturing and pharmacy distribution much differently than the U.S. market. (link below)

Vantage Hemp Co. avatar
Vantage Hemp Co.@vantagehemp·May 20

"From FDA Drug Master Files and global GMP certifications to clinical trial readiness and healthcare integration, Vantage Hemp is positioning itself very differently than most of the industry." Tune into @TheDalesReport now! (link below)

Vantage Hemp Co. avatar
Vantage Hemp Co.@vantagehemp·May 19

Tune in at 40 minutes and learn why healthcare operators, pharmacy leaders, and accountable care organizations are paying attention to Dr. Shields thedalesreport.com/cannabis/…

Vantage Hemp Co. avatar
Vantage Hemp Co.@vantagehemp·May 19

Vantage Standard is now a weekly segment @TheDalesReport Tune in at the 40 minute mark of last week's episode as Dr. Paul Shields passionately explains his REACH ACO-targeted Neuropathic Pain Medication Optimization Pathway. Watch the interview in the next post.

Post attachment
Vantage Hemp Co. avatar
Vantage Hemp Co.@vantagehemp·Apr 1

Vantage Hemp appoints Rusty Kuchta, RPh as CEO Rusty is a pharmacist and entrepreneur with 25+ years across retail, LTC, hospice, and PBM. As the Medicare CBD pilot takes flight, pharmacy + benefits integration will define program success. #Medicare #ACO #CBD #ValueBasedCare

Post attachment
Vantage Hemp Co. avatar
Vantage Hemp Co.@vantagehemp·Mar 24

Dr. Paul Shields joins Vantage Hemp as CMO to lead strategy for the emerging Medicare CBD pilot. • REACH ACO + oncology pathway expertise • Clinical governance + formulary design • Pharma-grade, DMF-backed CBD APIs Dr. Shields will drive execution inside value-based care.

Post attachment
Vantage Hemp Co. avatar
Vantage Hemp Co.@vantagehemp·Jan 15

Last month’s Executive Order on rescheduling marks a meaningful shift for our industry. To help our customers and partners understand the implications, we teamed up with The Distrio to produce: "Schedule 3 and Vantage Hemp: Trump's Rescheduling and CBD for Medicare" #Schedule3

President Donald Trump’s recent executive order rescheduling cannabis to a Schedule III controlled substance marks the most momentous shift in U.S. federal drug policy since 1970. We used DistrioGPT to produce a deep dive report on what this means for pharmaceutical grade CBD producer, Vantage Hemp Co. If you are curious about the potential changes to cannabis regulation in the United States, this report is a helpful resource. (Link in reply)

Post attachment